Company Anticipates Filing its 10-Q by the Statutory Deadline of Monday,
November 16th
EATONTOWN, N.J.--(Business Wire)--
EMRISE CORPORATION (NYSE Arca: ERI), a multi-national manufacturer of defense
and aerospace electronic devices and communications equipment, today announced
that the release of its results and the conference call for the third quarter
and nine months ended September 30, 2009, which were originally scheduled for
Wednesday, November 11, 2009, have been postponed in order to allow the Company
more time to finalize its third quarter financial results. The Company
anticipates filing its 10-Q by the statutory deadline of Monday, November 16th.
The Company will announce in advance the new date and time of the news release
and conference call.
About EMRISE CORPORATION
EMRISE designs, manufactures and markets electronic devices, sub-systems and
equipment for aerospace, defense, industrial and communications markets. EMRISE
products perform key functions such as power supply and power conversion; RF and
microwave signal processing; network access and timing and synchronization of
communications networks. Primary growth driver applications for EMRISE products
include RF devices for RCIED jamming systems and Edge Network Timing and
Synchronization equipment. EMRISE serves customers in North America, Europe and
Asia through operations in the United States, England and France. The Company
has built a worldwide base of customers including a majority of the Fortune 100
in the U.S. that do business in markets served by EMRISE and many similar-size
companies in Europe and Asia. For more information go to www.emrise.com.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
With the exception of historical information, the matters discussed in this
press release may be interpreted as forward looking statements. The actual
future results of EMRISE, including its ability to file its 10-Q by the
statutory deadline of Monday, November 16th could differ from those statements.
Factors that could cause or contribute to such differences are contained in the
"Risk Factors" Section of EMRISE`s Form 10-K for the year ended December 31,
2008, Form 10-Q`s for the quarterly periods ended March 31, 2009 and June 30,
2009, as amended, and other EMRISE filings with the Securities and Exchange
Commission.
EMRISE CORPORATION
John Donovan
Chief Financial Officer
732-387-5790
jdonovan@emrise.com
or
Allen & Caron Inc
Rene Caron (investors)
Len Hall (media)
949-474-4300
rene@allencaron.com
len@allencaron.com
Copyright Business Wire 2009
